Abstract: The present invention relates to the use of known 2-phenyl-substituted imidazotriazinones having short, unbranched alkyl radicals in the 9-position and cGMP PDE-inhibitory properties for the treatment of cardiac insufficiency, cancer, bladder disorders, or prostate hyperplasia.

Abstract: The present invention relates to the use of known 2-phenyl-substituted imidazotriazinones having short, unbranched alkyl radicals in the 9-position and cGMP PDE-inhibitory properties for the production of medicaments for the treatment of cardiac insufficiency, psoriasis, female infertility, cancer, diabetes, ophthalmic disorders such as glaucoma, disorders of gastric motility, cystic fibrosis, premature labour, pulmonary hypertension, bladder disorders, prostate hyperplasia, nitrate-induced tolerance, pre-eclampsia, alopecia, Parkinson's disease, pain, tinnitus or the renal syndrome.

Abstract: The present invention relates to the use of known 2-phenyl-substituted imidazotriazinones having short, unbranched alkyl radicals in the 9-position and cGMP PDE-inhibitory properties for the production of medicaments for the treatment of cardiac insufficiency, psoriasis, female infertility, cancer, diabetes, ophthalmic disorders such as glaucoma, disorders of gastric motility, cystic fibrosis, premature labour, pulmonary hypertension, bladder disorders, prostate hyperplasia, nitrate-induced tolerance, pre-eclampsia, alopecia, Parkinson's disease, pain, tinnitus or the renal syndrome.

Abstract: The present invention relates to the use of known 2-phenyl-substituted imidazotriazinones having short, unbranched alkyl radicals in the 9-position and cGMP PDE-inhibitory properties for the production of medicaments for the treatment of cardiac insufficiency, psoriasis, female infertility, cancer, diabetes, ophthalmic disorders such as glaucoma, disorders of gastric motility, cystic fibrosis, premature labour, pulmonary hypertension, bladder disorders, prostate hyperplasia, nitrate-induced tolerance, pre-eclampsia, alopecia, Parkinson's disease, pain, tinnitus or the renal syndrome.

Abstract: The present invention relates to imidazotriazinone-containing compositions for nasal administration which, besides the cGMP PDE inhibitor, contain a small amount of a local anaesthetic.

Abstract: The present invention relates to the use of known 2-phenyl-substituted imidazotriazinones having short, unbranched alkyl radicals in the 9-position and cGMP PDE-inhibitory properties for the production of medicaments for the treatment of cardiac insufficiency, psoriasis, female infertility, cancer, diabetes, ophthalmic disorders such as glaucoma, disorders of gastric motility, cystic fibrosis, premature labour, pulmonary hypertension, bladder disorders, prostate hyperplasia, nitrate-induced tolerance, pre-eclampsia, alopecia, Parkinson's disease, pain, tinnitus or the renal syndrome.

Abstract: The present invention relates to the use of PDE 5 inhibitors generally and in particular of 2-phenyl-substituted imidazotriazinones for the production of a medicament for improving the perception, concentration power, learning power and/or memory power, in particular for the treatment and/or prophylaxis of disorders of the perception, concentration power, learning power and/or memory power.

Abstract: The invention relates to compositions for nasal application containing cGMP-PDE inhibitors, especially PDE5 inhibitors, also containing a small amount of local anaesthetic in addition to said cGMP PDE inhibitor.

Abstract: The present invention relates to imidazotriazinone-containing compositions for nasal administration which, besides the cGMP PDE inhibitor, contain a small amount of a local anaesthetic.

Abstract: The present invention relates to imidazotriazinone-containing compositions for nasal administration which, besides the cGMP PDE inhibitor, contain a small amount of a local anaesthetic.

Abstract: A guide arrangement for elevators, particularly for vertical elevators. The guide arrangement is arranged in a shaft having a shaft wall. The guide arrangement includes a self-contained inherently stiff rail frame with at least two parallel guide rails which are rigidly connected to each other, the guide arrangement further includes fastening members for connecting the rail frame to the shaft wall, wherein the fastening members are springs.

Abstract: The invention deals with a cable tensioning system for elevators with separate drive cable and support cable lines 10, 11, which both engage at an elevator cabin 12 and also at a counterweight 13, characterized in that the cable tensioning system comprises a rocker 20 configured as a lever and supported at the counterweight 13 or the elevator cad 12, at which rocker the support cable 11 and the drive cable 10 are fastened to be spaced from each other, that the spacing ratio a: b of the attachment points 31, 32 of the cable lines 10, 12 at the rocker 20 from the support point 21 of the rocker 20 at the counterweight 13 or the elevator cab 12 define the cable tension or pull ratio required for the driving capacity.

Abstract: The invention deals with a cable tensioning system for elevators with separate drive cable and support cable lines 10, 11, which both engage at an elevator cabin 12 and also at a counterweight 13, characterized in that the cable tensioning system comprises a rocker 20 configured as a lever and supported at the counterweight 13 or the elevator cab 12, at which rocker the support cable 11 and the drive cable 10 are fastened to be spaced from each other, that the spacing ratio a:b of the attachment points 31, 32 of the cable lines 10, 12 at the rocker 20 from the support point 21 of the rocker 20 at the counterweight 13 or the elevator cab 12 define the cable tension or pull ratio required for the driving capacity.

Abstract: A safety catch device for elevator cars guided on at least one guide rail includes a braking device acting on the at least one guide rail for braking the elevator car and a control device for controlling the braking force of the braking device in dependence on the load and/or deceleration. The control device includes a control mass which is influenced by the acceleration of the elevator car and a brake spring which is deflected in accordance with the position of the control mass. The brake spring is coupled to the control mass and the braking device in such a way that a reduced braking force is applied by the braking device on the at least one guide rail in the case of a high deceleration of the elevator car and an increased braking force is applied by the braking device on the at least one guide rail in the case of a lower deceleration of the elevator car.

Abstract: A pneumatic motor having a plurality of cylinders, with each cylinder having an expansion chamber (15), defined in part by a piston plate (2); and a diversion chamber (16) which is divided into two chambers by a slide plate (11), with the diversion chambers connected to a pressure supply line (27) and to a pressure diversion line (28). The piston plate is connected to a piston rod (5) by a lock (3). The expansion chamber holds an amount of compressed air held constant throughout the operation cycle. Expansion of the expansion chamber moves the piston plate and piston rod (5) to rotate a crankshaft (5a). At the end of the expansion stroke, the piston rod is disconnected from the piston plate. The expansion chamber is compressed by pressurizing the diversion chamber below the slide plate (11), forcing the slide plate and push rods (7) upwards, which pushes the piston plate upwards, until the piston plate can be held at a top position by a lock (3').

Abstract: Cycloalkylidene derivatives of the general formulae Ia to Ic ##STR1## where the dashed line is a possible additional chemical bond, the radicals R.sup.1 are identical or different C.sub.1 -C.sub.4 -alkenyl groups, R.sup.2 and R.sup.3 are each methyl or ethyl, R.sup.4 is hydrogen or one of the radicals R.sup.1, X is oxygen, methylene or a chemical bond, m is from 0 to 3 or, when X is methylene, is from 1 to 3, or, when X is methylene and R.sup.1 is methyl, is from 2 to 3 and n is from 0 to 3, are used as fragrance materials.